Explore All Access
Check if your research matches the topics covered in Cancer Genomics and Proteomics?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cancer Genomics and Proteomics : Impact Factor & More
eISSN: 1790-6245pISSN: 1109-6535
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Cancer Genomics and Proteomics Key Metrics
CiteScore 
6.2
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Genetics
SNIP
0.94
Topics Covered on Cancer Genomics and Proteomics
Hepatocellular carcinoma
Genotype
Colorectal cancer
Medulloblastoma
Vector control
Histone deacetylase
Prostate cancer
Extracellular vesicles
Renal carcinoma
Overall survival
Immunohistochemistry
Substrate-level phosphorylation
Gene expression
Breast cancer
Conditioned medium
Senescence
Fusion gene
Betel quid chewing
Xeroderma pigmentosum
Androgen receptor
Cancer Genomics and Proteomics Journal Specifications
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
Planning to publish in Cancer Genomics and Proteomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Genomics and Proteomics
Gene Expression Profiling Regulated by lncRNA H19 Using Bioinformatic Analyses in Glioma Cell Lines.
- 28 Oct 2024
- Cancer genomics & proteomics
Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma.
- 28 Oct 2024
- Cancer genomics & proteomics
GD2 in Breast Cancer: A Potential Biomarker and Therapeutic Target.
- 28 Oct 2024
- Cancer genomics & proteomics
Cordycepin Activates Autophagy to Suppress FGF9-induced TM3 Mouse Leydig Progenitor Cell Proliferation.
- 28 Oct 2024
- Cancer genomics & proteomics
Impact of Hypoxia and the Levels of Transcription Factor HIF-1α and JMJD1A on Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cell Lines.
- 28 Oct 2024
- Cancer genomics & proteomics
Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time.
- 28 Oct 2024
- Cancer genomics & proteomics
Gene Expression Profiling Regulated by lncRNA H19 Using Bioinformatic Analyses in Glioma Cell Lines.
- 28 Oct 2024
- Cancer genomics & proteomics
Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma.
- 28 Oct 2024
- Cancer genomics & proteomics
GD2 in Breast Cancer: A Potential Biomarker and Therapeutic Target.
- 28 Oct 2024
- Cancer genomics & proteomics
Cordycepin Activates Autophagy to Suppress FGF9-induced TM3 Mouse Leydig Progenitor Cell Proliferation.
- 28 Oct 2024
- Cancer genomics & proteomics
Impact of Hypoxia and the Levels of Transcription Factor HIF-1α and JMJD1A on Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cell Lines.
- 28 Oct 2024
- Cancer genomics & proteomics
Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time.
- 28 Oct 2024
- Cancer genomics & proteomics
Compare Similar Journals with Cancer Genomics and Proteomics
Select Journals to Compare with Cancer Genomics and Proteomics
Total journals - 10
You can select up to 3 Journals at a time
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancers
Publisher: MDPI
Scientific Reports
Publisher: NATURE PORTFOLIO
Oncotarget
Publisher: Impact Journals
International Journal of Molecular Sciences
Publisher: MDPI
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
BMC Cancer
Publisher: BMC
0 Journals Selected to compare with
Cancer Genomics and Proteomics
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cancer Genomics and Proteomics
How long has Cancer Genomics and Proteomics been actively publishing? 
Cancer Genomics and Proteomics has been in operation since 2004 till date.
What is the publishing frequency of Cancer Genomics and Proteomics?
Cancer Genomics and Proteomics published with a Bi-monthly frequency.
How many articles did Cancer Genomics and Proteomics publish last year?
In 2024, Cancer Genomics and Proteomics publsihed 47 articles.
What is the eISSN & pISSN for Cancer Genomics and Proteomics?
For Cancer Genomics and Proteomics, eISSN is 1790-6245 and pISSN is 1109-6535.
What is Citescore for Cancer Genomics and Proteomics?
Citescore for Cancer Genomics and Proteomics is 6.2.
What is SNIP score for Cancer Genomics and Proteomics?
SNIP score for Cancer Genomics and Proteomics is 0.94.
What is the SJR for Cancer Genomics and Proteomics?
SJR for Cancer Genomics and Proteomics is Q2.
Who is the publisher of Cancer Genomics and Proteomics?
INT INST ANTICANCER RESEARCH is the publisher of Cancer Genomics and Proteomics.
